MTOR and breast neoplasm: In fact, our previous work revealed that although sfRon-driven breast tumor progression is strongly associated with activation of PI3K signaling, it does not appear to be through the AKT/mTOR pathway, because inhibition of AKT or mTOR was not able to suppress any of the tumor promoting functions of sfRon [3].